White House Reviewing Rule To Both Remove & Create New Safe Harbor Protections For Drug Rebates

By John Wilkerson / July 19, 2018 at 10:00 AM
The White House Office of Management and Budget is reviewing an HHS Inspector General proposal to both remove safe harbor protections and create new ones for drug rebates, according to the title of the proposed rule. Sources say that description might mean CMS is banning, or limiting, rebates that are calculated as a percentage of list prices while allowing rebates used in value-based purchasing arrangements. The proposed rule is listed as under review and there is little additional information beyond...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.